Foyston, Gordon, & Payne Inc Sanofi Transaction History

Foyston, Gordon, & Payne Inc

$392 Million
Q3 2024

A detailed history of Foyston, Gordon, & Payne Inc transactions in Sanofi stock. As of the latest transaction made, Foyston, Gordon, & Payne Inc holds 5,784 shares of SNY stock, worth $275,954. This represents 0.09% of its overall portfolio holdings.

Number of Shares

5,784

Previous 30,012 80.73%

Holding current value

$275,954

Previous $1.46 Million 77.13%

% of portfolio

0.09%

Previous 0.37%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$48.54 - $58.53 $1.18 Million - $1.42 Million	-24,228 Reduced 80.73%	5,784 $333,000
Q2 2024 Jul 30, 2024	SELL	$45.39 - $50.36 $86,422 - $95,885	-1,904 Reduced 5.97%	30,012 $1.46 Million
Q1 2024 May 07, 2024	SELL	$45.75 - $52.48 $41,769 - $47,914	-913 Reduced 2.78%	31,916 $1.55 Million
Q4 2023 Feb 07, 2024	SELL	$43.13 - $54.79 $424,140 - $538,804	-9,834 Reduced 23.05%	32,829 $1.63 Million
Q3 2023 Oct 26, 2023	BUY	$50.95 - $55.2 $157,180 - $170,292	3,085 Added 7.79%	42,663 $2.29 Million
Q2 2023 Aug 01, 2023	SELL	$50.45 - $57.18 $98,327 - $111,443	-1,949 Reduced 4.69%	39,578 $2.13 Million
Q1 2023 May 03, 2023	SELL	$45.86 - $54.45 $317,763 - $377,284	-6,929 Reduced 14.3%	41,527 $2.26 Million
Q4 2022 Feb 09, 2023	SELL	$38.86 - $48.55 $125,634 - $156,962	-3,233 Reduced 6.25%	48,456 $2.35 Million
Q3 2022 Nov 04, 2022	BUY	$37.22 - $100.5 $1.72 Million - $4.65 Million	46,225 Added 845.99%	51,689 $1.97 Million
Q2 2022 Aug 11, 2022	SELL	$48.99 - $57.46 $1.93 Million - $2.27 Million	-39,430 Reduced 87.83%	5,464 $2.08 Million
Q1 2022 Apr 27, 2022	SELL	$48.48 - $53.65 $25,064 - $27,737	-517 Reduced 1.14%	44,894 $2.31 Million
Q4 2021 Feb 11, 2022	SELL	$47.07 - $52.35 $91,786 - $102,082	-1,950 Reduced 4.12%	45,411 $2.28 Million
Q3 2021 Nov 12, 2021	SELL	$47.89 - $53.12 $46,213 - $51,260	-965 Reduced 2.0%	47,361 $2.28 Million
Q2 2021 Aug 06, 2021	BUY	$49.36 - $54.25 $284,708 - $312,914	5,768 Added 13.55%	48,326 $2.55 Million
Q1 2021 May 14, 2021	BUY	$45.46 - $50.51 $118,832 - $132,033	2,614 Added 6.54%	42,558 $2.11 Million
Q4 2020 Feb 12, 2021	SELL	$45.3 - $51.62 $379,115 - $432,007	-8,369 Reduced 17.32%	39,944 $1.94 Million
Q3 2020 Nov 12, 2020	SELL	$49.47 - $53.77 $196,148 - $213,198	-3,965 Reduced 7.58%	48,313 $2.42 Million
Q2 2020 Aug 14, 2020	SELL	$42.91 - $52.5 $163,572 - $200,130	-3,812 Reduced 6.8%	52,278 $2.67 Million
Q1 2020 May 15, 2020	SELL	$38.02 - $51.66 $155,159 - $210,824	-4,081 Reduced 6.78%	56,090 $2.45 Million
Q4 2019 Feb 14, 2020	SELL	$44.25 - $50.86 $190,983 - $219,511	-4,316 Reduced 6.69%	60,171 $3.02 Million
Q3 2019 Nov 14, 2019	BUY	$40.34 - $46.64 $53,329 - $61,658	1,322 Added 2.09%	64,487 $2.99 Million
Q2 2019 Aug 15, 2019	SELL	$40.43 - $44.3 $55,025 - $60,292	-1,361 Reduced 2.11%	63,165 $2.73 Million
Q1 2019 May 14, 2019	SELL	$40.83 - $45.43 $1.42 Million - $1.58 Million	-34,774 Reduced 35.02%	64,526 $2.86 Million
Q4 2018 Feb 08, 2019	BUY	$41.48 - $45.59 $4.12 Million - $4.53 Million	99,300 New	99,300 $4.31 Million
Q1 2018 May 14, 2018	SELL	$38.98 - $45.76 $929,672 - $1.09 Million	-23,850 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	23,850	23,850 $1.14 Million

Others Institutions Holding SNY

# of Institutions

822

Shares Held

268M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foyston, Gordon, & Payne Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foyston, Gordon, & Payne Inc with notifications on news.

Account

Foyston, Gordon, & Payne Inc Sanofi Transaction History